DGAP-Adhoc: 4SC AG issues first tranche of convertible notes with a nominal amount of EUR 500,000 to Yorkville

| Source: EQS Group AG
4SC AG  / Key word(s): Corporate Action/Miscellaneous

04.03.2014 16:15

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of an ad hoc release pursuant to Section 15 of the German
Securities Trading Act (Wertpapierhandelsgesetz, WpHG)

4SC AG issues first tranche of convertible notes with a nominal amount of
EUR 500,000 to Yorkville

Planegg-Martinsried, 4 March 2014 - 4SC AG (Frankfurt, Prime Standard: VSC)
today announced that it successfully completed the issuance of convertible
notes with a nominal amount of EUR 500,000.00. These convertible notes
constitute the first tranche of a total issuance of up to EUR 15 million
guaranteed by an agreement between YA Global Master SPV Ltd. ("Yorkville")
and the Company. Following the successful conversion of previously issued
tranches, the Company's Management will decide independently on a
case-by-case basis whether additional tranches will be issued.

Excluding the pre-emptive rights of existing shareholders, the notes will
be issued exclusively to Yorkville at a subscription price corresponding to
95% of the nominal amount. The notes carry no interest, have a term of nine
month and may be converted into shares of 4SC by the holder of the notes at
any time. The conversion price equals the volume weighted average trading
price of 4SC shares during a five-day period prior to the time of
conversion, less a 5% discount, but it cannot be lower than EUR 1.13.

Further details regarding the terms and conditions in connection with the
issuance of convertible notes according to the agreement with Yorkville
were announced in the ad hoc release dated 12 February 2014.

Ad hoc ends


Information and Explaination of the Issuer to this News:

About 4SC 

The Group managed by 4SC AG (ISIN DE0005753818) discovers and develops
targeted, small-molecule drugs for treating diseases with high unmet
medical needs in various cancer and autoimmune indications. These drugs are
intended to provide innovative treatment options that are more tolerable
and efficacious than existing therapies, and provide a better quality of
life. The Company's pipeline comprises promising products that are in
various stages of clinical development. 4SC's aim is to generate future
growth and enhance its enterprise value by entering into partnerships with
leading pharmaceutical and biotech companies. Founded in 1997, 4SC had a
headcount of 78 employees (57 FTEs) at 30 September 2013. 4SC AG has been
listed on the Prime Standard of the Frankfurt Stock Exchange since December

Cautionary statement regarding forward-looking statements 

This press release contains certain forward-looking statements. Any
forward-looking statement applies only on the date of this press release.
By their nature, forward-looking statements are subject to a number of
known and unknown risks and uncertainties that may or may not occur in the
future and as a result of which the actual results and performance may
differ substantially from the expected future results or performance
expressed or implied in the forward looking statements. No warranties or
representations are made as to the accuracy, achievement or reasonableness
of such statements, estimates or projections, and 4SC AG has no obligation
to update any such information or to correct any inaccuracies herein or
omission herefrom which may become apparent.

For more information please visit www.4sc.com or contact:

Jochen Orlowski, Corporate Communications & Investor Relations
jochen.orlowski(at)4sc.com, Tel.: +49-89-7007-6366

MC Services 
Raimund Gabriel
raimund.gabriel(at)mc-services.eu , Tel.: +49-89-2102-2830

The Trout Group 
Chad Rubin 
crubin(at)troutgroup.com, Tel.: +1-646-378-2947

04.03.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

Language:     English
Company:      4SC AG
              Am Klopferspitz 19a
              82152 Martinsried
Phone:        +49 (0)89 7007 63-0
Fax:          +49 (0)89 7007 63-29
E-mail:       public@4sc.com
Internet:     www.4sc.de
ISIN:         DE0005753818
WKN:          575381
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, München, Stuttgart
End of Announcement                             DGAP News-Service